vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
21.03
-0.71 (-3.27%)
Nov 6, 2026, 4:00 PM EST - Market closed
vTv Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 36.84 | - | 1.02 | - | 2.02 | 4.01 | |
Revenue Growth | 216600.00% | - | - | - | -49.61% | -37.56% |
Cost of Revenue | 17.86 | 17.86 | 11.55 | 13.6 | 12.36 | 12.62 |
Gross Profit | 18.98 | -17.86 | -10.53 | -13.6 | -10.34 | -8.62 |
Selling, General & Admin | 18.63 | 14.95 | 13.65 | 11.91 | 12.2 | 11.44 |
Operating Expenses | 29.96 | 14.95 | 13.65 | 11.91 | 12.2 | 11.44 |
Operating Income | -10.98 | -32.81 | -24.18 | -25.5 | -22.54 | -20.06 |
Interest Expense | -0 | -0.01 | - | -0.01 | -0.02 | -0.01 |
Interest & Investment Income | 3.25 | 1.87 | 1.57 | 0.47 | 0.35 | 0 |
Other Non Operating Income (Expenses) | 0.05 | -0.14 | 0.01 | 0.57 | 0.92 | 1.61 |
EBT Excluding Unusual Items | -7.68 | -31.08 | -22.61 | -24.47 | -21.29 | -18.46 |
Merger & Restructuring Charges | - | - | - | - | - | -1.6 |
Gain (Loss) on Sale of Investments | - | - | - | -1.18 | -3.59 | 2.45 |
Other Unusual Items | - | - | - | -0.31 | - | - |
Pretax Income | -7.68 | -31.08 | -22.61 | -25.97 | -24.87 | -17.62 |
Income Tax Expense | - | - | 0.1 | - | 0.2 | 0.12 |
Earnings From Continuing Operations | -7.68 | -31.08 | -22.71 | -25.97 | -25.07 | -17.73 |
Minority Interest in Earnings | - | 4.11 | 4.24 | 5.72 | 5.91 | 4.74 |
Net Income | -7.68 | -26.97 | -18.46 | -20.25 | -19.16 | -12.99 |
Net Income to Common | -7.68 | -26.97 | -18.46 | -20.25 | -19.16 | -12.99 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 12 | 8 | 6 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | 12 | 8 | 6 | 2 | 2 | 2 |
Shares Change | 78.56% | 45.96% | 176.79% | 8.60% | 22.58% | 32.90% |
EPS (Basic) | -0.62 | -3.20 | -3.20 | -9.71 | -9.98 | -8.29 |
EPS (Diluted) | -0.62 | -3.20 | -3.20 | -9.71 | -9.98 | -8.29 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -25.26 | -25.31 | -19.08 | -16.04 | -19.31 |
Free Cash Flow Per Share | - | -3.00 | -4.38 | -9.15 | -8.36 | -12.33 |
Gross Margin | 51.52% | - | - | - | - | -215.21% |
Operating Margin | -29.80% | - | -2377.58% | - | -1116.95% | -500.92% |
Profit Margin | -20.84% | - | -1815.34% | - | -949.65% | -324.27% |
Free Cash Flow Margin | - | - | -2488.40% | - | -795.00% | -482.10% |
EBITDA | -10.97 | -32.79 | -24.09 | -25.41 | -22.45 | -19.97 |
EBITDA Margin | -29.79% | - | - | - | - | - |
D&A For EBITDA | 0.01 | 0.02 | 0.09 | 0.09 | 0.09 | 0.09 |
EBIT | -10.98 | -32.81 | -24.18 | -25.5 | -22.54 | -20.06 |
EBIT Margin | -29.80% | - | - | - | - | - |